Insider trading

Period: 12 months Type of trade: Sold × Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

32,852 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

32,852 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

32,852 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

32,852 decisions over 12 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
32,852 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
32,852 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

32,852 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
1 Dec 2025
Dodge R Stanton Chief Legal Officer
Sold on a plan 2×
$1.79M 52,777 at 33.84
9.3%
Planned (10b5-1)
1 Dec 2025
Butcher Arthur C EVP& Grp Pres, MedSurg & APAC
Sold on a plan
$1.76M 17,313 at 101.55
42.3%
Planned (10b5-1)
1 Dec 2025
Kline Kyle Senior Vice President, CFO
Sold on a plan
$1.67M 18,542 at 90.00
100%
Sold half or more
1 Dec 2025
Lewis Karla R President, CEO
Sold at will 2×
$1.65M 5,809 at 283.50
6.4%
Not planned
1 Dec 2025
Maduck Sean See Remarks
Sold on a plan
$1.59M 20,000 at 79.52
71.7%
Sold half or more
1 Dec 2025
Bahrami Homa Director
Sold at will
$1.59M 3,500 at 453.75
16.0%
Not planned
1 Dec 2025
Jain Vivek EVP, Global Operations
Sold at will
$1.57M 5,914 at 265.84
13.2%
Not planned
1 Dec 2025
KHAYKIN OLEG President & CEO
Sold at will 2×
$1.51M 85,836 at 17.63
4.1%
Not planned
1 Dec 2025
Cromwell Thomas G EVP and COO
Sold on a plan
$1.50M 5,000 at 299.39
24.8%
Planned (10b5-1)
1 Dec 2025
Small Martin CFO & Senior Managing Director
Sold at will
$1.31M 1,258 at 1,043.38
16.8%
Not planned
1 Dec 2025
Roberts Chad EVP, Production Solutions
Sold on a plan
$1.31M 77,389 at 16.94
23.3%
Planned (10b5-1)
1 Dec 2025
LONG BRIAN Director · indirect
Sold at will
$1.22M 142,150 at 8.55
63.9%
Sold half or more
1 Dec 2025
Silverman Josh Chief Executive Officer
Sold on a plan 3×
$1.18M 21,666 at 54.67
21.5%
Planned (10b5-1)
1 Dec 2025
Liu Dongfang CHIEF MEDICAL OFFICER
Sold at will
$1.17M 150,000 at 7.82
89.3%
Sold half or more
1 Dec 2025
Nagendran Sukumar President and Head of R&D
Sold at will
$1.17M 260,047 at 4.51
20.5%
Not planned
1 Dec 2025
Farquhar Scott Director · indirect
Sold on a plan 6×
$1.17M 7,665 at 152.04
4.5%
Planned (10b5-1)
1 Dec 2025
Cannon-Brookes Michael CEO, Co-Founder · indirect
Sold on a plan 6×
$1.17M 7,665 at 152.04
4.5%
Planned (10b5-1)
1 Dec 2025
Ahamad Samsheer See Remarks
Sold on a plan
$1.16M 4,000 at 291.10
7.2%
Planned (10b5-1)
1 Dec 2025
Veinstein Bar President, A&G
Sold on a plan
$1.16M 309,902 at 3.74
26.7%
Planned (10b5-1)
1 Dec 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$1.15M 191,854 at 5.98
1.4%
Planned (10b5-1)
1 Dec 2025
Torley Helen PRESIDENT AND CEO
Sold on a plan 4×
$1.14M 16,569 at 68.92
2.3%
Planned (10b5-1)
1 Dec 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 3×
$1.05M 4,400 at 238.07
3.0%
Planned (10b5-1)
1 Dec 2025
Giancarlo Charles H Director · indirect
Sold on a plan 3×
$1.02M 8,000 at 128.09
23.7%
Planned (10b5-1)
1 Dec 2025
Wong Leila Chief Human Resources Officer
Sold at will
$1.02M 3,160 at 323.38
18.5%
Not planned
1 Dec 2025
LIPPS RANDALL A CHAIRMAN, PRESIDENT AND CEO
Sold on a plan
$1.02M 28,250 at 35.97
6.8%
Planned (10b5-1)
1 Dec 2025
Sold on a plan
$978.74K 50,000 at 19.57
6.2%
Planned (10b5-1)
1 Dec 2025
Cole Martin I Director
Sold on a plan 8×
$975.70K 6,000 at 162.62
14.5%
Planned (10b5-1)
1 Dec 2025
Sold on a plan
$948.12K 4,827 at 196.42
4.2%
Planned (10b5-1)
1 Dec 2025
Mann Paul Elliot Executive Chairman
Sold on a plan
$932.87K 162,153 at 5.75
2.0%
Planned (10b5-1)
1 Dec 2025
Urist Marshall EVP, Research & Investments · indirect
Sold on a plan
$931.63K 23,333 at 39.93
11.3%
Planned (10b5-1)
1 Dec 2025
Sundaram Mani EVP and GM Security · indirect
Sold on a plan
$931.60K 10,438 at 89.25
43.5%
Planned (10b5-1)
1 Dec 2025
Saba Capital Management, L.P. 10% owner · indirect
Sold at will
$871.94K 54,394 at 16.03
0.2%
Not planned
1 Dec 2025
Koch Stephen Paul Exec. VP, COO
Sold at will 3×
$869.39K 3,066 at 283.56
17.9%
Not planned
1 Dec 2025
Miosi Salvatore A President & COO
Sold on a plan
$852.03K 30,000 at 28.40
18.8%
Planned (10b5-1)
1 Dec 2025
CAFARO DEBRA A Chairman and CEO
Sold on a plan
$831.42K 10,322 at 80.55
0.9%
Planned (10b5-1)
1 Dec 2025
OHAYER MATTHEW EXECUTIVE CHAIRPERSON
Sold on a plan 2×
$829.19K 25,000 at 33.17
0.4%
Planned (10b5-1)
1 Dec 2025
Robinson Jill L. EVP, CFO & Treasurer
Sold on a plan
$789.18K 20,000 at 39.46
22.5%
Planned (10b5-1)
1 Dec 2025
HAYNE RICHARD A CEO & Chairman of the Board
Sold on a plan 2×
$789.06K 10,667 at 73.97
0.1%
Planned (10b5-1)
1 Dec 2025
Kelly Martin Chief Financial Officer
Sold at will
$788.43K 6,000 at 131.41
1.8%
Not planned
1 Dec 2025
HUME RICHARD T Director
Sold on a plan 2×
$760.55K 5,000 at 152.11
8.7%
Planned (10b5-1)
1 Dec 2025
Zegart Amy Director · indirect
Sold at will
$741.67K 10,000 at 74.17
100%
Sold half or more
1 Dec 2025
Jagdfeld Aaron Chief Executive Officer
Sold on a plan
$741.35K 5,000 at 148.27
0.9%
Planned (10b5-1)
1 Dec 2025
Urist Marshall EVP, Research & Investments
Sold on a plan
$727.86K 18,242 at 39.90
41.6%
Planned (10b5-1)
1 Dec 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 4×
$714.46K 3,000 at 238.15
2.7%
Planned (10b5-1)
1 Dec 2025
Dean Lia Pres, Banking & Prem. Products
Sold on a plan
$713.13K 3,269 at 218.15
4.5%
Planned (10b5-1)
1 Dec 2025
Cline Christopher R. CHIEF FINANCIAL OFFICER
Sold on a plan
$700.20K 20,000 at 35.01
17.8%
Planned (10b5-1)
1 Dec 2025
HAYNE RICHARD A CEO & Chairman of the Board · indirect
Sold on a plan 2×
$690.38K 9,333 at 73.97
0.4%
Planned (10b5-1)
1 Dec 2025
Hayne Margaret Co-President & CCO · indirect
Sold on a plan 2×
$690.38K 9,333 at 73.97
0.4%
Planned (10b5-1)
1 Dec 2025
GLENN T MICHAEL Director
Sold on a plan
$684.20K 6,558 at 104.33
17.4%
Planned (10b5-1)
1 Dec 2025
Sold at will
$655.81K 4,166 at 157.42
100%
Sold half or more
Showing 29,001–29,050 of 32,852. ← Newer Page 581 of 658 Older →